Industries > Pharma > Pharmaceutical Flexible Manufacturing Market Report 2021-2031
Pharmaceutical Flexible Manufacturing Market Report 2021-2031
Forecasts by Type (Modular Manufacturing, Data-Driven Manufacturing, Others), End-user (Pharma Companies, CMOs) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Flexible Manufacturing Companies AND COVID-19 Recovery Scenarios
Increased Focus on Reducing Manufacturing Costs
The pharmaceutical sector is demanding a growing number of specialized products that may only be used by a limited number of patients, and regulatory authorities are facilitating this trend by offering a variety of expedited clearance processes for these products. Furthermore, the ever-expanding product range demands the utilization of more flexible and agile facilities, with a greater emphasis on decreasing manufacturing costs and less confidence in future demand for particular goods. A range of techniques, including a modular approach, continuous processing, single-use technologies & new operational models among others must be activated to meet this need for new types of facilities & manufacturing processes.
Indian Pharmaceutical Flexible Manufacturing Anticipated to Witness Highest Growth Rate Over the Next Decade
According to Visiongain analysis, the Indian pharmaceutical flexible manufacturing market is anticipated to witness the highest growth rate of xx% from 2021 to 2031. The region is expected to reach US$xx billion in 2031 from its previous revenue of US$xx billion in 2021. This is due to a number of factors, including population growth, GDP per capita, regulatory regimes, and disease incidence. With these economic metrics, the region’s pharmaceutical industry is responding to modern technologies, innovation, and digital transformation to drive industry reforms. All these factors are anticipated to fuel Indian pharmaceutical flexible manufacturing market growth over the forecast period.
Discover how to stay ahead
Our 480-page report provides 400+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at the overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Pharmaceutical Flexible Manufacturing Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), Porter’s Five Forces, & SWOT Analysis, product profiles and commercial developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect your industry.
To access the data contained in this document please email contactus@visiongain.com
Discover sales predictions for the world market and submarkets
By Type
• Modular Manufacturing
• Data-Driven Manufacturing
• Others
By End-Use
• Pharmaceutical Companies
• CMO
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets:
By Region
• North America
• U.S.
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Australia
• Singapore
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa
Need industry data? Please contact us today.
Leading companies and the potential for market growth
Overall world revenue for the pharmaceutical flexible manufacturing market will surpass US$xx billion in 2021, our work calculates. We predict strong revenue growth through 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Pharmaceutical Flexible Manufacturing Market report helps you
In summary, our 480-page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Pharmaceutical Flexible Manufacturing Market, with forecasts for Type and End-Use, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 17 key national markets– See forecasts for the Pharmaceutical Flexible Manufacturing market in North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, India, and Japan, among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 27 of the major companies involved in the Pharmaceutical Flexible Manufacturing market. Some of the companies profiled in this report include Cytiva, G-CON Manufacturing, Pharmadule Morimatsu, NNE, IPM Technologies, KeyPlants, Germfree Laboratories, ModuleCo Ltd., Modwave, Environmental Systems Corporation, Avon Modular Construction, Exyte, Zeton, Pfizer, Solix Technologies, Inc., Thermo Fisher Scientific Inc., NextPharma Technologies, Continuus Pharmaceuticals, Merck KGaA, Boehringer Ingelheim International GmbH, Lonza, Sartorius AG, Danaher, Eppendorf AG, Rentschler Biopharma SE, PBS Biotech, Inc., and Entegris among other prominent players.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Pharmaceutical Flexible Manufacturing Market and leading companies. You will find data, trends, and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Pharmaceutical Flexible Manufacturing Market Report 2021-2031: Forecasts by Type (Modular Manufacturing, Data-Driven Manufacturing, Others), End-user (Pharma Companies, CMOs) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Flexible Manufacturing Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Introduction to Pharmaceutical Flexible Manufacturing Market
1.2 Pharmaceutical Flexible Manufacturing Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Outlook
3.1 Drivers
3.1.1 Increased Focus on Reducing Manufacturing Costs
3.1.2 Continuous Manufacturing Anticipated to Fuel Market Demand
3.1.3 Emerging Specialty Drug Products to Fuel Market Growth
3.1.4 Emergence of New Players
3.1.5 Increasing Popularity of Single Use Systems for Biopharmaceuticals
3.2 Restraints
3.2.1 Planning And Scheduling Of Production In Response To Short-Term Demand Fluctuations
3.2.2 Capacity and Investment Planning
3.2.3 De-centralized Manufacturing Trends
3.3 Opportunities
3.3.1 Extending Flexibility To The Design Of Plants
3.3.2 Fast Approvals And Market Take-up Of New Drugs
3.3.3 New Solutions To Provide The Necessary Agility And Flexibility For The New Pharma Reality
3.4 Trends
3.4.1 Generating Novel Large Molecule Drugs, Biopharmaceutical Businesses Are Experiencing More Obstacles Than Ever Before
3.4.2 CMOs Must Embrace Flexibility In Their Technology Decisions And Business Arrangements
3.4.3 Continuous Manufacturing Has The Potential To Be The Most Far-Reaching Of The New Flexible Technologies
3.5 SWOT Analysis
3.5.1 Strengths of Pharmaceutical Flexible Manufacturing Market
3.5.2 Weaknesses of Pharmaceutical Flexible Manufacturing Market
3.5.3 Opportunities of Pharmaceutical Flexible Manufacturing Market
3.5.4 Threats of Pharmaceutical Flexible Manufacturing Market
3.6 Porter’s Five Forces Analysis
3.6.1 Buyer Power
3.6.2 Supplier Power
3.6.3 Competitive Rivalry
3.6.4 Threat of Substitute
3.6.5 Threat of New Entrants
3.7 COVID-19 Impact on Pharmaceutical Manufacturing Sector
4 Pharmaceutical Flexible Manufacturing Market by Type
4.1 Modular Manufacturing Segment Market Forecast, 2021-2031
4.1.1 Modular Manufacturing Segment Market Overview
4.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.2 Data-Driven Manufacturing Segment Market Forecast, 2021-2031
4.2.1 Data-Driven Manufacturing Segment Market Overview
4.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.3 Others Segment Market Forecast, 2021-2031
4.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5 Pharmaceutical Flexible Manufacturing Market by End-User
5.1 Pharmaceutical Companies Segment Market Forecast, 2021-2031
5.1.1 Pharmaceutical Companies Segment Market Overview
5.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.2 CMO Segment Market Forecast, 2021-2031
5.2.1 CMOs Segment Market Overview
5.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6 Regional and Leading National Pharmaceutical Flexible Manufacturing Market Forecasts 2021-2031
6.1 Global Pharmaceutical Flexible Manufacturing Market by Region Forecast 2021-2031
6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7 North America Pharmaceutical Flexible Manufacturing Market
7.1 North America Accounts for Majority of the Global Pharmaceutical Flexible Manufacturing Market
7.2 North America Pharmaceutical Flexible Manufacturing Market by Country, Forecast 2021-2031
7.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031
7.3 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type
7.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031
7.4 North America Pharmaceutical Flexible Manufacturing Market Forecast by End-User
7.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031
7.5 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
7.5.1 U.S. Accounts for Majority of the North American Pharmaceutical Flexible Manufacturing Market
7.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
7.6 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
7.6.1 Canada Market Analysis
7.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8 Europe Pharmaceutical Flexible Manufacturing Market
8.1 Growing Investment in Expanding European Pharmaceutical Business to Offer Lucrative Growth Prospects
8.2 Europe Pharmaceutical Flexible Manufacturing Market by Country, Forecast 2021-2031
8.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031
8.3 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type
8.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031
8.4 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End-User
8.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031
8.5 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.5.1 Germany Market Analysis
8.5.2 Strong Industry Base
8.5.3 R&D Excellence and Innovation
8.5.4 Biologics and Biosimilars Market Trends Across Germany
8.5.5 COVID-19 Impact Recovery Scenarios (V, U, W, L): Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.6 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.6.1 Improvement in Manufacturing Processes to Fuel Market Growth
8.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.7 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.7.1 France Pharmaceutical Flexible Manufacturing Market to Witness Highest Growth Rate Through 2031
8.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.8 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.8.1 Research and Development is Crucial for Italian Market
8.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.9 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.9.1 Growing Pharmaceutical Sector to Fuel Spanish Pharmaceutical Flexible Manufacturing Market
8.9.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.10 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.10.1 Government Initiatives to Offer Lucrative Growth Prospects to Russian Pharmaceutical Flexible Business Over the Next Decade
8.10.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.11 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.11.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9 Asia Pacific Pharmaceutical Flexible Manufacturing Market
9.1 Asia Pacific Pharmaceutical Flexible Manufacturing Market to Witness Highest Growth Rate Through 2031
9.2 Asia Pacific Pharmaceutical Flexible Manufacturing Market by Country, Forecast 2021-2031
9.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031
9.3 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type
9.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031
9.4 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End-User
9.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031
9.5 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.5.1 Japanese Pharmaceutical Sector is Undergoing Significant Changes Which is Anticipated to Fuel Regional Growth
9.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.6 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.6.1 China Pharmaceutical Flexible Manufacturing Market Accounts for Majority of the Asia Pacific Market
9.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.7 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.7.1 India Pharmaceutical Flexible Manufacturing Market to Witness Highest Growth Rate Through 2031
9.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.8 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.8.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.9 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.10 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.10.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
10 Latin America Pharmaceutical Flexible Manufacturing Market
10.1 Increasing R&D Expenditure Across the Latin American Region to Fuel Market Growth
10.2 Latin America Pharmaceutical Flexible Manufacturing Market by Country, Forecast 2021-2031
10.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031
10.3 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type
10.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031
10.4 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End-User
10.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031
10.5 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
10.5.1 Brazil Accounts for Majority of the Latin American Pharmaceutical Flexible Manufacturing Market
10.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
10.6 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
10.6.1 Mexican Pharmaceutical Flexible Manufacturing Market Anticipated to be an Appealing Market Over the Next Decade
10.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
10.7 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
10.7.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
11 Middle East and Africa Pharmaceutical Flexible Manufacturing Market
11.1 Inclusion of FDI into Pharmaceutical Sector to Offer Lucrative Growth Prospects Over the Next Decade
11.2 Middle East and Africa Pharmaceutical Flexible Manufacturing Market by Country, Forecast 2021-2031
11.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031
11.3 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type
11.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031
11.4 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End-User
11.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031
11.5 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
11.5.1 GCC Market Analysis
11.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
11.6 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
11.6.1 South Africa Market Analysis
11.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
11.7 Rest of Middle East and Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
11.7.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
12 Competitive Landscape
12.1 Company Ranking
12.2 Strategic Framework
13 Company Profiles
13.1 Cytiva (Acquired by Danaher)
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Product Benchmarking
13.1.4 Recent Developments
13.2 G-CON Manufacturing
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Product Benchmarking
13.2.4 Recent Developments
13.3 Pharmadule Morimatsu
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Product Benchmarking
13.3.4 Recent Developments
13.4 NNE
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Product Benchmarking
13.4.4 Recent Developments
13.5 IPM Technologies
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Product Benchmarking
13.6 KeyPlants
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Product Benchmarking
13.6.4 Recent Developments
13.7 Germfree Laboratories
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Product Benchmarking
13.7.4 Recent Developments
13.8 ModuleCo Ltd.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Product Benchmarking
13.9 Modwave
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Product Benchmarking
13.10 Environmental Systems Corporation
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Product Benchmarking
13.11 Avon Modular Construction
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Product Benchmarking
13.12 Exyte
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Product Benchmarking
13.12.4 Recent Developments
13.13 Zeton
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Product Benchmarking
13.14 Pfizer
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Analysis
13.14.4 Product Benchmarking
13.14.5 Recent Developments
13.15 Solix Technologies, Inc.
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Product Benchmarking
13.15.4 Recent Developments
13.16 Thermo Fisher Scientific Inc.
13.16.1 Company Snapshot
13.16.2 Company Overview
13.16.3 Financial Analysis
13.16.4 Product Benchmarking
13.16.5 Recent Developments
13.17 NextPharma Technologies
13.17.1 Company Snapshot
13.17.2 Company Overview
13.17.3 Product Benchmarking
13.17.4 Recent Developments
13.18 Continuus Pharmaceuticals
13.18.1 Company Snapshot
13.18.2 Company Overview
13.18.3 Product Benchmarking
13.18.4 Recent Developments
13.19 Merck KGaA
13.19.1 Company Snapshot
13.19.2 Company Overview
13.19.3 Financial Analysis
13.19.4 Product Benchmarking
13.19.5 Recent Developments
13.20 Boehringer Ingelheim International GmbH
13.20.1 Company Snapshot
13.20.2 Company Overview
13.20.3 Financial Analysis
13.20.4 Product Benchmarking
13.20.5 Recent Developments
13.21 Lonza
13.21.1 Company Snapshot
13.21.2 Company Overview
13.21.3 Financial Analysis
13.21.4 Product Benchmarking
13.21.5 Recent Developments
13.22 Sartorius AG
13.22.1 Company Snapshot
13.22.2 Company Overview
13.22.3 Financial Analysis
13.22.4 Product Benchmarking
13.23 Eppendorf AG
13.23.1 Company Snapshot
13.23.2 Company Overview
13.23.3 Product Benchmarking
13.24 Rentschler Biopharma SE
13.24.1 Company Snapshot
13.24.2 Company Overview
13.24.3 Product Benchmarking
13.25 PBS Biotech, Inc.
13.25.1 Company Snapshot
13.25.2 Company Overview
13.25.3 Product Benchmarking
13.26 Entegris
13.26.1 Company Snapshot
13.26.2 Company Overview
13.26.3 Financial Analysis
13.26.4 Product Benchmarking
14 Conclusion and Recommendations
14.1 Concluding Remarks
14.2 Recommendations
List of Tables
Table 1 Global Pharmaceutical Flexible Manufacturing Market Snapshot, 2021 & 2031 (US$ billion, CAGR %)
Table 2 Global Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 3 Global Pharmaceutical Flexible Manufacturing Market Forecast for Modular Manufacturing Segment, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 4 Global Pharmaceutical Flexible Manufacturing Market Forecast for Modular Manufacturing Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 5 Global Pharmaceutical Flexible Manufacturing Market Forecast for Modular Manufacturing Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 6 Global Pharmaceutical Flexible Manufacturing Market Forecast for Modular Manufacturing Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 7 Global Pharmaceutical Flexible Manufacturing Market Forecast for Modular Manufacturing Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 8 Global Pharmaceutical Flexible Manufacturing Market Forecast by Data-Driven Manufacturing Segment, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 9 Global Pharmaceutical Flexible Manufacturing Market Forecast by Data-Driven Manufacturing Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 10 Global Pharmaceutical Flexible Manufacturing Market Forecast by Data-Driven Manufacturing Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 11 Global Pharmaceutical Flexible Manufacturing Market Forecast by Data-Driven Manufacturing Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 12 Global Pharmaceutical Flexible Manufacturing Market Forecast by Data-Driven Manufacturing Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 13 Global Pharmaceutical Flexible Manufacturing Market Forecast for Others Segment, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 14 Global Pharmaceutical Flexible Manufacturing Market Forecast for Others Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 15 Global Pharmaceutical Flexible Manufacturing Market Forecast for Others Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 16 Global Pharmaceutical Flexible Manufacturing Market Forecast for Others Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 17 Global Pharmaceutical Flexible Manufacturing Market Forecast for Others Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 18 Global Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 19 Global Pharmaceutical Flexible Manufacturing Market Forecast for Pharmaceutical Companies Segment, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 20 Global Pharmaceutical Flexible Manufacturing Market Forecast for Pharmaceutical Companies Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 21 Global Pharmaceutical Flexible Manufacturing Market Forecast for Pharmaceutical Companies Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 22 Global Pharmaceutical Flexible Manufacturing Market Forecast for Pharmaceutical Companies Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 23 Global Pharmaceutical Flexible Manufacturing Market Forecast for Pharmaceutical Companies Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 24 Global Pharmaceutical Flexible Manufacturing Market Forecast for CMO Segment, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 25 Global Pharmaceutical Flexible Manufacturing Market Forecast for CMO Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 26 Global Pharmaceutical Flexible Manufacturing Market Forecast for CMO Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 27 Global Pharmaceutical Flexible Manufacturing Market Forecast for CMO Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 28 Global Pharmaceutical Flexible Manufacturing Market Forecast for CMO Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 29 Global Pharmaceutical Flexible Manufacturing Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 30 Global Pharmaceutical Flexible Manufacturing Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 31 Global Pharmaceutical Flexible Manufacturing Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 32 Global Pharmaceutical Flexible Manufacturing Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 33 Global Pharmaceutical Flexible Manufacturing Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 34 North America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 35 North America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 36 North America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 37 North America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 38 North America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 39 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 40 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 41 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 42 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 43 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 44 North America Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 45 North America Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 46 North America Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 47 North America Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 48 North America Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 49 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 50 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 51 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 52 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 53 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 54 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 55 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 56 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 57 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 58 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 59 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 60 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 61 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 62 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 63 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 64 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 65 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 66 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 67 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 68 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 69 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 70 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 71 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 72 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 73 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 74 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 75 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 76 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 77 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 78 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 79 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 80 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 81 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 82 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 83 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 84 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 85 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 86 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 87 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 88 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 89 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 90 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 91 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 92 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 93 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 94 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 95 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 96 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 97 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 98 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 99 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 100 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 101 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 102 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 103 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 104 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 105 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 106 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 107 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 108 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 109 APAC Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 110 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 111 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 112 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 113 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 114 APAC Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 115 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 116 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 117 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 118 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 119 APAC Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 120 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 121 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 122 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 123 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 124 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 125 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 126 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 127 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 128 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 129 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 130 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 131 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 132 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 133 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 134 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 135 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 136 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 137 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 138 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 139 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 140 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 141 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 142 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 143 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 144 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 145 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 146 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 147 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 148 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 149 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 150 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 151 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 152 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 153 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 154 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 155 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 156 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 157 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 158 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 159 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 160 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 161 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 162 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 163 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 164 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 165 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 166 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 167 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 168 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 169 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 170 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 171 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 172 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 173 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 174 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 175 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 176 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 177 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 178 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 179 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 180 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 181 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 182 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 183 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 184 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 185 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 186 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 187 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 188 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 189 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 190 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 191 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 192 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 193 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 194 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 195 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 196 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 197 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 198 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 199 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 200 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 201 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 202 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 203 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 204 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 205 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 206 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 207 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 208 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 209 Rest of MEA Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 210 Rest of MEA Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 211 Rest of MEA Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 212 Rest of MEA Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 213 Rest of MEA Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 214 Company Ranking, 2020
Table 215 Recent Developments, 2019-2021
Table 216 Cytiva: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 217 Cytiva: Product Benchmarking
Table 218 Cytiva: Recent Developments
Table 219 G-CON Manufacturing: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 220 G-CON Manufacturing: Product Benchmarking
Table 221 G-CON Manufacturing: Recent Developments
Table 222 Pharmadule Morimatsu: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 223 Pharmadule Morimatsu: Product Benchmarking
Table 224 Pharmadule Morimatsu: Recent Developments
Table 225 NNE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 226 NNE: Product Benchmarking
Table 227 NNE: Recent Developments
Table 228 IPM Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 229 IPM Technologies: Product Benchmarking
Table 230 KeyPlants: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 231 KeyPlants: Product Benchmarking
Table 232 KeyPlants: Recent Developments
Table 233 Germfree Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 234 Germfree Laboratories: Product Benchmarking
Table 235 Germfree Laboratories: Recent Developments
Table 236 ModuleCo Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 237 ModuleCo Ltd.: Product Benchmarking
Table 238 Modwave: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 239 Modwave: Product Benchmarking
Table 240 Environmental Systems Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 241 Environmental Systems Corporation: Product Benchmarking
Table 242 Avon Modular Construction: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 243 Avon Modular Construction: Product Benchmarking
Table 244 Exyte: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 245 Exyte: Product Benchmarking
Table 246 Exyte: Recent Developments
Table 247 Zeton: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 248 Zeton: Product Benchmarking
Table 249 Pfizer: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 250 Pfizer: Product Benchmarking
Table 251 Pfizer: Recent Developments
Table 252 Solix Technologies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 253 Solix Technologies, Inc.: Product Benchmarking
Table 254 Solix Technologies, Inc.: Recent Developments
Table 255 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 256 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 257 Thermo Fisher Scientific Inc.: Recent Developments
Table 258 NextPharma Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 259 NextPharma Technologies: Product Benchmarking
Table 260 NextPharma Technologies: Recent Developments
Table 261 Continuus Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 262 Continuus Pharmaceuticals: Product Benchmarking
Table 263 Continuus Pharmaceuticals: Recent Developments
Table 264 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 265 Merck KGaA: Product Benchmarking
Table 266 Merck KGaA: Recent Developments
Table 267 Boehringer Ingelheim International GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 268 Boehringer Ingelheim International GmbH: Product Benchmarking
Table 269 Boehringer Ingelheim International GmbH: Recent Developments
Table 270 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 271 Lonza: Product Benchmarking
Table 272 Lonza: Recent Developments
Table 273 Sartorius AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 274 Sartorius AG: Product Benchmarking
Table 275 Eppendorf AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 276 Eppendorf AG: Product Benchmarking
Table 277 Rentschler Biopharma SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 278 Rentschler Biopharma SE: Product Benchmarking
Table 279 PBS Biotech, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 280 PBS Biotech, Inc.: Product Benchmarking
Table 281 Entegris: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 282 Entegris: Product Benchmarking
List of Figures
Figure 1 Global Pharmaceutical Flexible Manufacturing Market: Market Segmentation
Figure 2 Global Pharmaceutical Flexible Manufacturing Market: Market Outlook
Figure 3 Porter’s Analysis
Figure 4 Global Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR %)
Figure 5 Global Pharmaceutical Flexible Manufacturing Market Share Forecast by Type, 2021, 2026, 2031 (%)
Figure 6 Global Pharmaceutical Flexible Manufacturing Market for Modular Manufacturing Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 7 Global Pharmaceutical Flexible Manufacturing Market for Modular Manufacturing Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 8 Global Pharmaceutical Flexible Manufacturing Market for Modular Manufacturing Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 9 Global Pharmaceutical Flexible Manufacturing Market for Modular Manufacturing Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 10 Global Pharmaceutical Flexible Manufacturing Market for Modular Manufacturing Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 11 Global Pharmaceutical Flexible Manufacturing Market for Data-Driven Manufacturing Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 12 Global Pharmaceutical Flexible Manufacturing Market for Data-Driven Manufacturing Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 13 Global Pharmaceutical Flexible Manufacturing Market for Data-Driven Manufacturing Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 14 Global Pharmaceutical Flexible Manufacturing Market for Data-Driven Manufacturing Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 15 Global Pharmaceutical Flexible Manufacturing Market for Data-Driven Manufacturing Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 16 Global Pharmaceutical Flexible Manufacturing Market for Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 17 Global Pharmaceutical Flexible Manufacturing Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 18 Global Pharmaceutical Flexible Manufacturing Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 19 Global Pharmaceutical Flexible Manufacturing Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 20 Global Pharmaceutical Flexible Manufacturing Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 21 Global Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR %)
Figure 22 Global Pharmaceutical Flexible Manufacturing Market Share Forecast by End-User, 2021, 2026, 2031 (%)
Figure 23 Global Pharmaceutical Flexible Manufacturing Market for Pharmaceutical Companies Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 24 Global Pharmaceutical Flexible Manufacturing Market for Pharmaceutical Companies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 25 Global Pharmaceutical Flexible Manufacturing Market for Pharmaceutical Companies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 26 Global Pharmaceutical Flexible Manufacturing Market for Pharmaceutical Companies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 27 Global Pharmaceutical Flexible Manufacturing Market for Pharmaceutical Companies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 28 Global Pharmaceutical Flexible Manufacturing Market for CMO Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 29 Global Pharmaceutical Flexible Manufacturing Market for CMO Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 30 Global Pharmaceutical Flexible Manufacturing Market for CMO Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 31 Global Pharmaceutical Flexible Manufacturing Market for CMO Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 32 Global Pharmaceutical Flexible Manufacturing Market for CMO Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 33 Global Pharmaceutical Flexible Manufacturing Market Forecast by Region 2021-2031 (US$ billion)
Figure 34 Global Pharmaceutical Flexible Manufacturing Market Share Forecast by Region 2021, 2026, 2031 (%)
Figure 35 Global Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 36 Global Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 37 Global Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 38 Global Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 39 North America Pharmaceutical Flexible Manufacturing Market Forecast by Country 2021-2031 (US$ billion)
Figure 40 North America Pharmaceutical Flexible Manufacturing Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 41 North America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 42 North America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 43 North America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 44 North America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 45 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%)
Figure 46 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 47 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 48 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 49 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 50 North America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%)
Figure 51 North America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 52 North America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 53 North America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 54 North America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 55 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 56 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 57 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 58 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 59 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 60 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 61 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 62 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 63 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 64 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 65 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country 2021-2031 (US$ billion)
Figure 66 Europe Pharmaceutical Flexible Manufacturing Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 67 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 68 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 69 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 70 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 71 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%)
Figure 72 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 73 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 74 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 75 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 76 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%)
Figure 77 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 78 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 79 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 80 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 81 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 82 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 83 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 84 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 85 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 86 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 87 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 88 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 89 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 90 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 91 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 92 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 93 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 94 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 95 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 96 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 97 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 98 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 99 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 100 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 101 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 102 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 103 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 104 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 105 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 106 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 107 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 108 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 109 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 110 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 111 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 112 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 113 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 114 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 115 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 116 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Country 2021-2031 (US$ billion)
Figure 117 Asia Pacific Pharmaceutical Flexible Manufacturing Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 118 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 119 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 120 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 121 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 122 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 123 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 124 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 125 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 126 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 127 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 128 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 129 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 130 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 131 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 132 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 133 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 134 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 135 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 136 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 137 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 138 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 139 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 140 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 141 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 142 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 143 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 144 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 145 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 146 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 147 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 148 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 149 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 150 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 151 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 152 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 153 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 154 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 155 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 156 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 157 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 158 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 159 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 160 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 161 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 162 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country 2021-2031 (US$ million)
Figure 163 Latin America Pharmaceutical Flexible Manufacturing Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 164 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 165 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 166 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 167 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 168 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 169 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 170 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 171 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 172 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 173 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 174 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 175 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 176 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 177 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 178 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 179 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 180 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 181 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 182 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 183 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 184 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 185 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 186 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 187 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 188 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 189 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 190 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 191 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 192 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 193 Middle East and Africa Pharmaceutical Flexible Manufacturing Market Forecast by Country 2021-2031 (US$ million)
Figure 194 Middle East and Africa Pharmaceutical Flexible Manufacturing Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 195 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 196 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 197 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 198 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 199 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 200 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 201 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 202 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 203 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 204 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 205 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 206 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 207 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 208 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 209 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 210 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 211 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 212 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 213 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 214 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 215 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 216 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 217 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 218 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 219 Rest of Middle East and Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 220 Rest of Middle East and Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 221 Rest of Middle East and Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 222 Rest of Middle East and Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 223 Rest of Middle East and Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 224 Pfizer: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 225 Pfizer: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 226 Pfizer: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 227 Pfizer: Net Income, 2015-2020 (US$ million, AGR%)
Figure 228 Pfizer: EBDITA, 2015-2020 (US$ million, AGR%)
Figure 229 Thermo Fisher Scientific Inc.: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 230 Thermo Fisher Scientific Inc.: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 231 Thermo Fisher Scientific Inc.: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 232 Thermo Fisher Scientific Inc.: Net Income, 2015-2020 (US$ million, AGR%)
Figure 233 Thermo Fisher Scientific Inc.: EBDITA, 2015-2020 (US$ million, AGR%)
Figure 234 Merck KGaA: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 235 Merck KGaA: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 236 Merck KGaA: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 237 Merck KGaA: Net Income, 2015-2020 (US$ million, AGR%)
Figure 238 Merck KGaA: EBDITA, 2015-2020 (US$ million, AGR%)
Figure 239 Boehringer Ingelheim International GmbH: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 240 Lonza: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 241 Lonza: R&D Expenses, 2017-2019 (US$ million, AGR%)
Figure 242 Lonza: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 243 Lonza: Net Income, 2015-2020 (US$ million, AGR%)
Figure 244 Lonza: EBDITA, 2015-2020 (US$ million, AGR%)
Figure 245 Sartorius AG: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 246 Sartorius AG: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 247 Sartorius AG: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 248 Sartorius AG: Net Income, 2015-2020 (US$ million, AGR%)
Figure 249 Sartorius AG: EBDITA, 2015-2020 (US$ million, AGR%)
Figure 250 Entegris: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 251 Entegris: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 252 Entegris: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 253 Entegris: Net Income, 2015-2020 (US$ million, AGR%)
Figure 254 Entegris: EBDITA, 2015-2020 (US$ million, AGR%)
1.1 Introduction to Pharmaceutical Flexible Manufacturing Market
1.2 Pharmaceutical Flexible Manufacturing Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Outlook
3.1 Drivers
3.1.1 Increased Focus on Reducing Manufacturing Costs
3.1.2 Continuous Manufacturing Anticipated to Fuel Market Demand
3.1.3 Emerging Specialty Drug Products to Fuel Market Growth
3.1.4 Emergence of New Players
3.1.5 Increasing Popularity of Single Use Systems for Biopharmaceuticals
3.2 Restraints
3.2.1 Planning And Scheduling Of Production In Response To Short-Term Demand Fluctuations
3.2.2 Capacity and Investment Planning
3.2.3 De-centralized Manufacturing Trends
3.3 Opportunities
3.3.1 Extending Flexibility To The Design Of Plants
3.3.2 Fast Approvals And Market Take-up Of New Drugs
3.3.3 New Solutions To Provide The Necessary Agility And Flexibility For The New Pharma Reality
3.4 Trends
3.4.1 Generating Novel Large Molecule Drugs, Biopharmaceutical Businesses Are Experiencing More Obstacles Than Ever Before
3.4.2 CMOs Must Embrace Flexibility In Their Technology Decisions And Business Arrangements
3.4.3 Continuous Manufacturing Has The Potential To Be The Most Far-Reaching Of The New Flexible Technologies
3.5 SWOT Analysis
3.5.1 Strengths of Pharmaceutical Flexible Manufacturing Market
3.5.2 Weaknesses of Pharmaceutical Flexible Manufacturing Market
3.5.3 Opportunities of Pharmaceutical Flexible Manufacturing Market
3.5.4 Threats of Pharmaceutical Flexible Manufacturing Market
3.6 Porter’s Five Forces Analysis
3.6.1 Buyer Power
3.6.2 Supplier Power
3.6.3 Competitive Rivalry
3.6.4 Threat of Substitute
3.6.5 Threat of New Entrants
3.7 COVID-19 Impact on Pharmaceutical Manufacturing Sector
4 Pharmaceutical Flexible Manufacturing Market by Type
4.1 Modular Manufacturing Segment Market Forecast, 2021-2031
4.1.1 Modular Manufacturing Segment Market Overview
4.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.2 Data-Driven Manufacturing Segment Market Forecast, 2021-2031
4.2.1 Data-Driven Manufacturing Segment Market Overview
4.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.3 Others Segment Market Forecast, 2021-2031
4.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5 Pharmaceutical Flexible Manufacturing Market by End-User
5.1 Pharmaceutical Companies Segment Market Forecast, 2021-2031
5.1.1 Pharmaceutical Companies Segment Market Overview
5.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.2 CMO Segment Market Forecast, 2021-2031
5.2.1 CMOs Segment Market Overview
5.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6 Regional and Leading National Pharmaceutical Flexible Manufacturing Market Forecasts 2021-2031
6.1 Global Pharmaceutical Flexible Manufacturing Market by Region Forecast 2021-2031
6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7 North America Pharmaceutical Flexible Manufacturing Market
7.1 North America Accounts for Majority of the Global Pharmaceutical Flexible Manufacturing Market
7.2 North America Pharmaceutical Flexible Manufacturing Market by Country, Forecast 2021-2031
7.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031
7.3 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type
7.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031
7.4 North America Pharmaceutical Flexible Manufacturing Market Forecast by End-User
7.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031
7.5 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
7.5.1 U.S. Accounts for Majority of the North American Pharmaceutical Flexible Manufacturing Market
7.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
7.6 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
7.6.1 Canada Market Analysis
7.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8 Europe Pharmaceutical Flexible Manufacturing Market
8.1 Growing Investment in Expanding European Pharmaceutical Business to Offer Lucrative Growth Prospects
8.2 Europe Pharmaceutical Flexible Manufacturing Market by Country, Forecast 2021-2031
8.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031
8.3 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type
8.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031
8.4 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End-User
8.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031
8.5 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.5.1 Germany Market Analysis
8.5.2 Strong Industry Base
8.5.3 R&D Excellence and Innovation
8.5.4 Biologics and Biosimilars Market Trends Across Germany
8.5.5 COVID-19 Impact Recovery Scenarios (V, U, W, L): Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.6 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.6.1 Improvement in Manufacturing Processes to Fuel Market Growth
8.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.7 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.7.1 France Pharmaceutical Flexible Manufacturing Market to Witness Highest Growth Rate Through 2031
8.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.8 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.8.1 Research and Development is Crucial for Italian Market
8.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.9 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.9.1 Growing Pharmaceutical Sector to Fuel Spanish Pharmaceutical Flexible Manufacturing Market
8.9.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.10 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.10.1 Government Initiatives to Offer Lucrative Growth Prospects to Russian Pharmaceutical Flexible Business Over the Next Decade
8.10.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.11 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
8.11.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9 Asia Pacific Pharmaceutical Flexible Manufacturing Market
9.1 Asia Pacific Pharmaceutical Flexible Manufacturing Market to Witness Highest Growth Rate Through 2031
9.2 Asia Pacific Pharmaceutical Flexible Manufacturing Market by Country, Forecast 2021-2031
9.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031
9.3 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type
9.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031
9.4 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End-User
9.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031
9.5 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.5.1 Japanese Pharmaceutical Sector is Undergoing Significant Changes Which is Anticipated to Fuel Regional Growth
9.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.6 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.6.1 China Pharmaceutical Flexible Manufacturing Market Accounts for Majority of the Asia Pacific Market
9.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.7 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.7.1 India Pharmaceutical Flexible Manufacturing Market to Witness Highest Growth Rate Through 2031
9.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.8 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.8.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.9 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.10 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
9.10.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
10 Latin America Pharmaceutical Flexible Manufacturing Market
10.1 Increasing R&D Expenditure Across the Latin American Region to Fuel Market Growth
10.2 Latin America Pharmaceutical Flexible Manufacturing Market by Country, Forecast 2021-2031
10.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031
10.3 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type
10.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031
10.4 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End-User
10.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031
10.5 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
10.5.1 Brazil Accounts for Majority of the Latin American Pharmaceutical Flexible Manufacturing Market
10.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
10.6 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
10.6.1 Mexican Pharmaceutical Flexible Manufacturing Market Anticipated to be an Appealing Market Over the Next Decade
10.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
10.7 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
10.7.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
11 Middle East and Africa Pharmaceutical Flexible Manufacturing Market
11.1 Inclusion of FDI into Pharmaceutical Sector to Offer Lucrative Growth Prospects Over the Next Decade
11.2 Middle East and Africa Pharmaceutical Flexible Manufacturing Market by Country, Forecast 2021-2031
11.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031
11.3 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type
11.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031
11.4 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End-User
11.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031
11.5 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
11.5.1 GCC Market Analysis
11.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
11.6 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
11.6.1 South Africa Market Analysis
11.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
11.7 Rest of Middle East and Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
11.7.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031
12 Competitive Landscape
12.1 Company Ranking
12.2 Strategic Framework
13 Company Profiles
13.1 Cytiva (Acquired by Danaher)
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Product Benchmarking
13.1.4 Recent Developments
13.2 G-CON Manufacturing
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Product Benchmarking
13.2.4 Recent Developments
13.3 Pharmadule Morimatsu
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Product Benchmarking
13.3.4 Recent Developments
13.4 NNE
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Product Benchmarking
13.4.4 Recent Developments
13.5 IPM Technologies
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Product Benchmarking
13.6 KeyPlants
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Product Benchmarking
13.6.4 Recent Developments
13.7 Germfree Laboratories
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Product Benchmarking
13.7.4 Recent Developments
13.8 ModuleCo Ltd.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Product Benchmarking
13.9 Modwave
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Product Benchmarking
13.10 Environmental Systems Corporation
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Product Benchmarking
13.11 Avon Modular Construction
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Product Benchmarking
13.12 Exyte
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Product Benchmarking
13.12.4 Recent Developments
13.13 Zeton
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Product Benchmarking
13.14 Pfizer
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Analysis
13.14.4 Product Benchmarking
13.14.5 Recent Developments
13.15 Solix Technologies, Inc.
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Product Benchmarking
13.15.4 Recent Developments
13.16 Thermo Fisher Scientific Inc.
13.16.1 Company Snapshot
13.16.2 Company Overview
13.16.3 Financial Analysis
13.16.4 Product Benchmarking
13.16.5 Recent Developments
13.17 NextPharma Technologies
13.17.1 Company Snapshot
13.17.2 Company Overview
13.17.3 Product Benchmarking
13.17.4 Recent Developments
13.18 Continuus Pharmaceuticals
13.18.1 Company Snapshot
13.18.2 Company Overview
13.18.3 Product Benchmarking
13.18.4 Recent Developments
13.19 Merck KGaA
13.19.1 Company Snapshot
13.19.2 Company Overview
13.19.3 Financial Analysis
13.19.4 Product Benchmarking
13.19.5 Recent Developments
13.20 Boehringer Ingelheim International GmbH
13.20.1 Company Snapshot
13.20.2 Company Overview
13.20.3 Financial Analysis
13.20.4 Product Benchmarking
13.20.5 Recent Developments
13.21 Lonza
13.21.1 Company Snapshot
13.21.2 Company Overview
13.21.3 Financial Analysis
13.21.4 Product Benchmarking
13.21.5 Recent Developments
13.22 Sartorius AG
13.22.1 Company Snapshot
13.22.2 Company Overview
13.22.3 Financial Analysis
13.22.4 Product Benchmarking
13.23 Eppendorf AG
13.23.1 Company Snapshot
13.23.2 Company Overview
13.23.3 Product Benchmarking
13.24 Rentschler Biopharma SE
13.24.1 Company Snapshot
13.24.2 Company Overview
13.24.3 Product Benchmarking
13.25 PBS Biotech, Inc.
13.25.1 Company Snapshot
13.25.2 Company Overview
13.25.3 Product Benchmarking
13.26 Entegris
13.26.1 Company Snapshot
13.26.2 Company Overview
13.26.3 Financial Analysis
13.26.4 Product Benchmarking
14 Conclusion and Recommendations
14.1 Concluding Remarks
14.2 Recommendations
List of Tables
Table 1 Global Pharmaceutical Flexible Manufacturing Market Snapshot, 2021 & 2031 (US$ billion, CAGR %)
Table 2 Global Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 3 Global Pharmaceutical Flexible Manufacturing Market Forecast for Modular Manufacturing Segment, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 4 Global Pharmaceutical Flexible Manufacturing Market Forecast for Modular Manufacturing Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 5 Global Pharmaceutical Flexible Manufacturing Market Forecast for Modular Manufacturing Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 6 Global Pharmaceutical Flexible Manufacturing Market Forecast for Modular Manufacturing Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 7 Global Pharmaceutical Flexible Manufacturing Market Forecast for Modular Manufacturing Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 8 Global Pharmaceutical Flexible Manufacturing Market Forecast by Data-Driven Manufacturing Segment, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 9 Global Pharmaceutical Flexible Manufacturing Market Forecast by Data-Driven Manufacturing Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 10 Global Pharmaceutical Flexible Manufacturing Market Forecast by Data-Driven Manufacturing Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 11 Global Pharmaceutical Flexible Manufacturing Market Forecast by Data-Driven Manufacturing Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 12 Global Pharmaceutical Flexible Manufacturing Market Forecast by Data-Driven Manufacturing Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 13 Global Pharmaceutical Flexible Manufacturing Market Forecast for Others Segment, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 14 Global Pharmaceutical Flexible Manufacturing Market Forecast for Others Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 15 Global Pharmaceutical Flexible Manufacturing Market Forecast for Others Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 16 Global Pharmaceutical Flexible Manufacturing Market Forecast for Others Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 17 Global Pharmaceutical Flexible Manufacturing Market Forecast for Others Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 18 Global Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 19 Global Pharmaceutical Flexible Manufacturing Market Forecast for Pharmaceutical Companies Segment, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 20 Global Pharmaceutical Flexible Manufacturing Market Forecast for Pharmaceutical Companies Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 21 Global Pharmaceutical Flexible Manufacturing Market Forecast for Pharmaceutical Companies Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 22 Global Pharmaceutical Flexible Manufacturing Market Forecast for Pharmaceutical Companies Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 23 Global Pharmaceutical Flexible Manufacturing Market Forecast for Pharmaceutical Companies Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 24 Global Pharmaceutical Flexible Manufacturing Market Forecast for CMO Segment, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 25 Global Pharmaceutical Flexible Manufacturing Market Forecast for CMO Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 26 Global Pharmaceutical Flexible Manufacturing Market Forecast for CMO Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 27 Global Pharmaceutical Flexible Manufacturing Market Forecast for CMO Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 28 Global Pharmaceutical Flexible Manufacturing Market Forecast for CMO Segment, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 29 Global Pharmaceutical Flexible Manufacturing Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 30 Global Pharmaceutical Flexible Manufacturing Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 31 Global Pharmaceutical Flexible Manufacturing Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 32 Global Pharmaceutical Flexible Manufacturing Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 33 Global Pharmaceutical Flexible Manufacturing Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 34 North America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 35 North America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 36 North America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 37 North America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 38 North America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 39 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 40 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 41 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 42 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 43 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 44 North America Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 45 North America Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 46 North America Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 47 North America Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 48 North America Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 49 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 50 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 51 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 52 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 53 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 54 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 55 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 56 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 57 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 58 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 59 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 60 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 61 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 62 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 63 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 64 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 65 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 66 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 67 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 68 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 69 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 70 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 71 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 72 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 73 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 74 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 75 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 76 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 77 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 78 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 79 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 80 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 81 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 82 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 83 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 84 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 85 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 86 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 87 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 88 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 89 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 90 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 91 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 92 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 93 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 94 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 95 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 96 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 97 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 98 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 99 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 100 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 101 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 102 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 103 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 104 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 105 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 106 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 107 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 108 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 109 APAC Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 110 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 111 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 112 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 113 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 114 APAC Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 115 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 116 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 117 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 118 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 119 APAC Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 120 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 121 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 122 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 123 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 124 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 125 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 126 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 127 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 128 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 129 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 130 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 131 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 132 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 133 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 134 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 135 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 136 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 137 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 138 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 139 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 140 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 141 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 142 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 143 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 144 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 145 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 146 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 147 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 148 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 149 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 150 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 151 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 152 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 153 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 154 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 155 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 156 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 157 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 158 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 159 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 160 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 161 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 162 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 163 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 164 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 165 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 166 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 167 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 168 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 169 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 170 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 171 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 172 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 173 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 174 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 175 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 176 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 177 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 178 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 179 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 180 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 181 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 182 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 183 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 184 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 185 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 186 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 187 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 188 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 189 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 190 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 191 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 192 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 193 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 194 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 195 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 196 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 197 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 198 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 199 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 200 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 201 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 202 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 203 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 204 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 205 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 206 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 207 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 208 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 209 Rest of MEA Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 210 Rest of MEA Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 211 Rest of MEA Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 212 Rest of MEA Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 213 Rest of MEA Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 214 Company Ranking, 2020
Table 215 Recent Developments, 2019-2021
Table 216 Cytiva: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 217 Cytiva: Product Benchmarking
Table 218 Cytiva: Recent Developments
Table 219 G-CON Manufacturing: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 220 G-CON Manufacturing: Product Benchmarking
Table 221 G-CON Manufacturing: Recent Developments
Table 222 Pharmadule Morimatsu: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 223 Pharmadule Morimatsu: Product Benchmarking
Table 224 Pharmadule Morimatsu: Recent Developments
Table 225 NNE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 226 NNE: Product Benchmarking
Table 227 NNE: Recent Developments
Table 228 IPM Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 229 IPM Technologies: Product Benchmarking
Table 230 KeyPlants: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 231 KeyPlants: Product Benchmarking
Table 232 KeyPlants: Recent Developments
Table 233 Germfree Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 234 Germfree Laboratories: Product Benchmarking
Table 235 Germfree Laboratories: Recent Developments
Table 236 ModuleCo Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 237 ModuleCo Ltd.: Product Benchmarking
Table 238 Modwave: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 239 Modwave: Product Benchmarking
Table 240 Environmental Systems Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 241 Environmental Systems Corporation: Product Benchmarking
Table 242 Avon Modular Construction: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 243 Avon Modular Construction: Product Benchmarking
Table 244 Exyte: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 245 Exyte: Product Benchmarking
Table 246 Exyte: Recent Developments
Table 247 Zeton: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 248 Zeton: Product Benchmarking
Table 249 Pfizer: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 250 Pfizer: Product Benchmarking
Table 251 Pfizer: Recent Developments
Table 252 Solix Technologies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 253 Solix Technologies, Inc.: Product Benchmarking
Table 254 Solix Technologies, Inc.: Recent Developments
Table 255 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 256 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 257 Thermo Fisher Scientific Inc.: Recent Developments
Table 258 NextPharma Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 259 NextPharma Technologies: Product Benchmarking
Table 260 NextPharma Technologies: Recent Developments
Table 261 Continuus Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 262 Continuus Pharmaceuticals: Product Benchmarking
Table 263 Continuus Pharmaceuticals: Recent Developments
Table 264 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 265 Merck KGaA: Product Benchmarking
Table 266 Merck KGaA: Recent Developments
Table 267 Boehringer Ingelheim International GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 268 Boehringer Ingelheim International GmbH: Product Benchmarking
Table 269 Boehringer Ingelheim International GmbH: Recent Developments
Table 270 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 271 Lonza: Product Benchmarking
Table 272 Lonza: Recent Developments
Table 273 Sartorius AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 274 Sartorius AG: Product Benchmarking
Table 275 Eppendorf AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 276 Eppendorf AG: Product Benchmarking
Table 277 Rentschler Biopharma SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 278 Rentschler Biopharma SE: Product Benchmarking
Table 279 PBS Biotech, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 280 PBS Biotech, Inc.: Product Benchmarking
Table 281 Entegris: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 282 Entegris: Product Benchmarking
List of Figures
Figure 1 Global Pharmaceutical Flexible Manufacturing Market: Market Segmentation
Figure 2 Global Pharmaceutical Flexible Manufacturing Market: Market Outlook
Figure 3 Porter’s Analysis
Figure 4 Global Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR %)
Figure 5 Global Pharmaceutical Flexible Manufacturing Market Share Forecast by Type, 2021, 2026, 2031 (%)
Figure 6 Global Pharmaceutical Flexible Manufacturing Market for Modular Manufacturing Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 7 Global Pharmaceutical Flexible Manufacturing Market for Modular Manufacturing Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 8 Global Pharmaceutical Flexible Manufacturing Market for Modular Manufacturing Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 9 Global Pharmaceutical Flexible Manufacturing Market for Modular Manufacturing Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 10 Global Pharmaceutical Flexible Manufacturing Market for Modular Manufacturing Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 11 Global Pharmaceutical Flexible Manufacturing Market for Data-Driven Manufacturing Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 12 Global Pharmaceutical Flexible Manufacturing Market for Data-Driven Manufacturing Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 13 Global Pharmaceutical Flexible Manufacturing Market for Data-Driven Manufacturing Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 14 Global Pharmaceutical Flexible Manufacturing Market for Data-Driven Manufacturing Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 15 Global Pharmaceutical Flexible Manufacturing Market for Data-Driven Manufacturing Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 16 Global Pharmaceutical Flexible Manufacturing Market for Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 17 Global Pharmaceutical Flexible Manufacturing Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 18 Global Pharmaceutical Flexible Manufacturing Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 19 Global Pharmaceutical Flexible Manufacturing Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 20 Global Pharmaceutical Flexible Manufacturing Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 21 Global Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR %)
Figure 22 Global Pharmaceutical Flexible Manufacturing Market Share Forecast by End-User, 2021, 2026, 2031 (%)
Figure 23 Global Pharmaceutical Flexible Manufacturing Market for Pharmaceutical Companies Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 24 Global Pharmaceutical Flexible Manufacturing Market for Pharmaceutical Companies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 25 Global Pharmaceutical Flexible Manufacturing Market for Pharmaceutical Companies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 26 Global Pharmaceutical Flexible Manufacturing Market for Pharmaceutical Companies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 27 Global Pharmaceutical Flexible Manufacturing Market for Pharmaceutical Companies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 28 Global Pharmaceutical Flexible Manufacturing Market for CMO Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 29 Global Pharmaceutical Flexible Manufacturing Market for CMO Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 30 Global Pharmaceutical Flexible Manufacturing Market for CMO Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 31 Global Pharmaceutical Flexible Manufacturing Market for CMO Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 32 Global Pharmaceutical Flexible Manufacturing Market for CMO Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 33 Global Pharmaceutical Flexible Manufacturing Market Forecast by Region 2021-2031 (US$ billion)
Figure 34 Global Pharmaceutical Flexible Manufacturing Market Share Forecast by Region 2021, 2026, 2031 (%)
Figure 35 Global Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 36 Global Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 37 Global Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 38 Global Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 39 North America Pharmaceutical Flexible Manufacturing Market Forecast by Country 2021-2031 (US$ billion)
Figure 40 North America Pharmaceutical Flexible Manufacturing Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 41 North America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 42 North America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 43 North America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 44 North America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 45 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%)
Figure 46 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 47 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 48 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 49 North America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 50 North America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%)
Figure 51 North America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 52 North America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 53 North America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 54 North America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 55 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 56 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 57 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 58 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 59 U.S. Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 60 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 61 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 62 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 63 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 64 Canada Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 65 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country 2021-2031 (US$ billion)
Figure 66 Europe Pharmaceutical Flexible Manufacturing Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 67 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 68 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 69 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 70 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 71 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%)
Figure 72 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 73 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 74 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 75 Europe Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 76 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%)
Figure 77 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 78 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 79 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 80 Europe Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 81 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 82 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 83 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 84 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 85 Germany Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 86 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 87 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 88 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 89 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 90 UK Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 91 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 92 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 93 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 94 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 95 France Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 96 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 97 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 98 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 99 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 100 Italy Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 101 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 102 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 103 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 104 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 105 Spain Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 106 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 107 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 108 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 109 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 110 Russia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 111 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 112 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 113 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 114 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 115 Rest of Europe Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 116 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Country 2021-2031 (US$ billion)
Figure 117 Asia Pacific Pharmaceutical Flexible Manufacturing Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 118 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 119 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 120 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 121 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 122 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 123 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 124 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 125 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 126 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 127 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 128 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 129 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 130 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 131 Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 132 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 133 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 134 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 135 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 136 Japan Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 137 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 138 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 139 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 140 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 141 China Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 142 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 143 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 144 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 145 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 146 India Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 147 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 148 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 149 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 150 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 151 Australia Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 152 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 153 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 154 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 155 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 156 Singapore Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 157 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 158 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 159 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 160 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 161 Rest of Asia Pacific Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 162 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country 2021-2031 (US$ million)
Figure 163 Latin America Pharmaceutical Flexible Manufacturing Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 164 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 165 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 166 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 167 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 168 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 169 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 170 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 171 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 172 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 173 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 174 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 175 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 176 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 177 Latin America Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 178 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 179 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 180 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 181 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 182 Brazil Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 183 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 184 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 185 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 186 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 187 Mexico Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 188 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 189 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 190 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 191 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 192 Rest of Latin America Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 193 Middle East and Africa Pharmaceutical Flexible Manufacturing Market Forecast by Country 2021-2031 (US$ million)
Figure 194 Middle East and Africa Pharmaceutical Flexible Manufacturing Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 195 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 196 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 197 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 198 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Country, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 199 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 200 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 201 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 202 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 203 MEA Pharmaceutical Flexible Manufacturing Market Forecast by Type, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 204 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 205 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 206 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 207 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 208 MEA Pharmaceutical Flexible Manufacturing Market Forecast by End-User, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 209 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 210 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 211 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 212 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 213 GCC Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 214 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 215 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 216 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 217 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 218 South Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 219 Rest of Middle East and Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 220 Rest of Middle East and Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 221 Rest of Middle East and Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 222 Rest of Middle East and Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 223 Rest of Middle East and Africa Pharmaceutical Flexible Manufacturing Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 224 Pfizer: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 225 Pfizer: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 226 Pfizer: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 227 Pfizer: Net Income, 2015-2020 (US$ million, AGR%)
Figure 228 Pfizer: EBDITA, 2015-2020 (US$ million, AGR%)
Figure 229 Thermo Fisher Scientific Inc.: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 230 Thermo Fisher Scientific Inc.: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 231 Thermo Fisher Scientific Inc.: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 232 Thermo Fisher Scientific Inc.: Net Income, 2015-2020 (US$ million, AGR%)
Figure 233 Thermo Fisher Scientific Inc.: EBDITA, 2015-2020 (US$ million, AGR%)
Figure 234 Merck KGaA: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 235 Merck KGaA: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 236 Merck KGaA: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 237 Merck KGaA: Net Income, 2015-2020 (US$ million, AGR%)
Figure 238 Merck KGaA: EBDITA, 2015-2020 (US$ million, AGR%)
Figure 239 Boehringer Ingelheim International GmbH: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 240 Lonza: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 241 Lonza: R&D Expenses, 2017-2019 (US$ million, AGR%)
Figure 242 Lonza: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 243 Lonza: Net Income, 2015-2020 (US$ million, AGR%)
Figure 244 Lonza: EBDITA, 2015-2020 (US$ million, AGR%)
Figure 245 Sartorius AG: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 246 Sartorius AG: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 247 Sartorius AG: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 248 Sartorius AG: Net Income, 2015-2020 (US$ million, AGR%)
Figure 249 Sartorius AG: EBDITA, 2015-2020 (US$ million, AGR%)
Figure 250 Entegris: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 251 Entegris: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 252 Entegris: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 253 Entegris: Net Income, 2015-2020 (US$ million, AGR%)
Figure 254 Entegris: EBDITA, 2015-2020 (US$ million, AGR%)
Companies Profiled in the Report
Avon Modular Construction
Boehringer Ingelheim International GmbH
Continuus Pharmaceuticals
Cytiva
Danaher
Entegris
Environmental Systems Corporation
Eppendorf AG
Exyte
G-CON Manufacturing
Germfree Laboratories
IPM Technologies
KeyPlants
Lonza
Merck KGaA
ModuleCo Ltd.
Modwave
NextPharma Technologies
NNE
PBS Biotech, Inc.
Pfizer
Pharmadule Morimatsu
Rentschler Biopharma SE
Sartorius AG
Solix Technologies, Inc.
Thermo Fisher Scientific Inc.
Zeton
List of Other Companies
3D Biotek
AbbVie
Amgen
Amixon
Applikon Biotechnology
AstraZeneca
Cell Culture Company
Cellec Biotek
Centre for Process Innovation
Design Integrated Technology
E.T. Oakes
Eli Lilly
Evaporators & Dryers Engineering
Freund
Gilead Sciences
Kevin Process Technologies
Kilburn Engineering
KORSCH
Merck
Metso
Munson Machinery
Neuhaus Neotec
Novartis
O'Hara Technologies
OmniBRx Biotechnologies
Pall Life Sciences
Patheon
Pierre Guerin
TA Instruments
Tema Process
Vertex
XPure
YMC Process Technologies
Zaiput Flow Technologies
List of Organizations
Association of International Pharmaceutical Manufacturers
Chinese Pharmaceutical Association
European Medicines Agency
Federal Drugs Agency
IFPMA
Indian Drug Manufacturers’ Association
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
Jordanian Association of Pharmaceutical Manufacturers
Medicines and Healthcare Products Regulatory Agency
National Association of Pharmaceutical Manufacturers
Pharma & Biopharma Outsourcing Association (PBOA)
Pharmaceutical Group of the European Union
Pharmaceutical Manufacturers Association (PMA)
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Royal Pharmaceutical Society
Singapore Association of Pharmaceutical Industries (SAPI)
Sri Lanka Pharmaceutical Manufacturers Association
The Association of the British Pharmaceutical Industry (ABPI)
The Australian Pharmaceutical Manufacturers Association
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association
Avon Modular Construction
Boehringer Ingelheim International GmbH
Continuus Pharmaceuticals
Cytiva
Danaher
Entegris
Environmental Systems Corporation
Eppendorf AG
Exyte
G-CON Manufacturing
Germfree Laboratories
IPM Technologies
KeyPlants
Lonza
Merck KGaA
ModuleCo Ltd.
Modwave
NextPharma Technologies
NNE
PBS Biotech, Inc.
Pfizer
Pharmadule Morimatsu
Rentschler Biopharma SE
Sartorius AG
Solix Technologies, Inc.
Thermo Fisher Scientific Inc.
Zeton
List of Other Companies
3D Biotek
AbbVie
Amgen
Amixon
Applikon Biotechnology
AstraZeneca
Cell Culture Company
Cellec Biotek
Centre for Process Innovation
Design Integrated Technology
E.T. Oakes
Eli Lilly
Evaporators & Dryers Engineering
Freund
Gilead Sciences
Kevin Process Technologies
Kilburn Engineering
KORSCH
Merck
Metso
Munson Machinery
Neuhaus Neotec
Novartis
O'Hara Technologies
OmniBRx Biotechnologies
Pall Life Sciences
Patheon
Pierre Guerin
TA Instruments
Tema Process
Vertex
XPure
YMC Process Technologies
Zaiput Flow Technologies
List of Organizations
Association of International Pharmaceutical Manufacturers
Chinese Pharmaceutical Association
European Medicines Agency
Federal Drugs Agency
IFPMA
Indian Drug Manufacturers’ Association
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
Jordanian Association of Pharmaceutical Manufacturers
Medicines and Healthcare Products Regulatory Agency
National Association of Pharmaceutical Manufacturers
Pharma & Biopharma Outsourcing Association (PBOA)
Pharmaceutical Group of the European Union
Pharmaceutical Manufacturers Association (PMA)
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Royal Pharmaceutical Society
Singapore Association of Pharmaceutical Industries (SAPI)
Sri Lanka Pharmaceutical Manufacturers Association
The Association of the British Pharmaceutical Industry (ABPI)
The Australian Pharmaceutical Manufacturers Association
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association
Download sample pages
Complete the form below to download your free sample pages for Pharmaceutical Flexible Manufacturing Market Report 2021-2031Related reports
-
Pharmacy Inventory Management Software Market Report 2020-2030
The increase in the prevalence of non-communicable diseases worldwide has led to an increase in demand for prescription medications.
...Full DetailsPublished: 01 January 1970 -
Automation in Biopharma Industry 2020-2030
The automation in biopharma industry market is estimated to grow at a CAGR of 4.3% over the forecast period.
...Full DetailsPublished: 30 April 2020 -
Big Data Analytics in Healthcare Market Report 2021-2031
Healthcare has never been more personalized and affordable to anyone. Digital consulting applications use artificial intelligence to provide medical advice...Full DetailsPublished: 11 May 2021 -
Pharma Contract Sales Market Report 2021-2031
Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their...Full DetailsPublished: 13 July 2021 -
Gene Therapy R&D Market Report 2021-2031
Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities,...Full DetailsPublished: 11 June 2021 -
Drug Delivery Technologies Market Report 2021-2031
Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand...Full DetailsPublished: 13 July 2021 -
Global Osteoporosis Pharmaceutical and Nutraceutical Market Report 2020-2030
Our 338-page report that includes 160 tables and 134 figures throws light on the pharmaceutical and nutraceutical market, the current...
Full DetailsPublished: 01 May 2020 -
Pharma Leader Series: Top 50 Ophthalmic Drug Manufacturers Market Report 2021-2031
The global market for ophthalmic drugs is increasing yearly. Your competitors in the ophthalmic drugs market are benefiting from key...Full DetailsPublished: 04 March 2021 -
Clinical Trial Supply and Logistics Market for Pharma 2020-2030
The global clinical trial supply and logistics market for pharma is estimated to have reach $10.3bn in 2019, dominated by...
Full DetailsPublished: 24 April 2020 -
Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021
Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry....Full DetailsPublished: 06 January 2021
Download sample pages
Complete the form below to download your free sample pages for Pharmaceutical Flexible Manufacturing Market Report 2021-2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034
The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.
23 April 2024
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024
Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034
The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.
12 April 2024
